KYTX
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm
LOS ANGELES , Dec. 30, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces...
Read moreDetails
February 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against KYTX
NEW YORK , Dec. 30, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kyverna Therapeutics,...
Read moreDetails
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX
NEW YORK, Dec. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers...
Read moreDetails
KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO , Dec. 28, 2024 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Kyverna...
Read moreDetails
KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. – KYTX
NEW ORLEANS , Dec. 27, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until...
Read moreDetails
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – KYTX
NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against...
Read moreDetails
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Securities Fraud Lawsuit
NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of...
Read moreDetails
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)
LOS ANGELES, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 7,...
Read moreDetails
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP
RADNOR, Pa. , Dec. 27, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that...
Read moreDetails
Kyverna Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX
NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. ("Kyverna Therapeutics, Inc."...
Read moreDetails